Page 1,673«..1020..1,6721,6731,6741,675..1,6801,690..»

Texas Children’s Hospital ranked No. 1 spot for cardiology, surgery … – CW39

Posted: Published on June 29th, 2017

children's hospital HOUSTON Texas Childrens Hospital is the best place for children to receive cardiology and heart surgery care in the nation, according to U.S. News & World Report. The organization listed the hospital system as No. 1 in its 2017-2018 edition of Best Childrens Hospitals. For more than half a century, the integrated, multidisciplinary team has combined cutting-edge technology with a compassionate and family-centered approach to care. Annually, more than 1,000 surgeries are performed and more than 26,000 patient encounters occur in the outpatient clinic. This unparalleled survey result is due to the dedicated work and passionate care our team provides children with heart diseases and defects each day, said Dr. Charles D. Fraser Jr., chief of congenital heart surgery and surgeon-in-chief at Texas Childrens Hospital. We continually strive to improve the quality of care for our cardiac patients by tracking our outcomes and remaining committed to developing innovative cardiac interventions and surgical treatment options to ensure optimum results for patients in need. Texas Childrens Heart Center cardiologists and surgeons are world-renowned leaders in pediatric cardiology, congenital heart surgery and cardiovascular anesthesiology, and strive to offer every procedure available for the treatment of pediatric heart diseases and defects for … Continue reading

Posted in Cardiology | Comments Off on Texas Children’s Hospital ranked No. 1 spot for cardiology, surgery … – CW39

Physician named to Beaufort Memorial Hospital board – Bluffton Today

Posted: Published on June 29th, 2017

Beaufort County Council has appointed Dr. Stacey Johnston to the Beaufort Memorial Hospital Board of Trustees. Johnston replaces pediatrician Dr. James Simmons, who stepped down this spring after serving 10 years on the nine-member board. A board-certified family medicine specialist, Johnston has been a hospitalist at Beaufort Memorial for eight years. She is a graduate of Emory University School of Medicine and completed her residency at Memorial University Medical Center in Savannah in 2009. Johnston is the chief medical information officer for the hospitalist program and has served as its medical director for the last five years. She served as a Girl Scouts leader in Beaufort for seven years. Johnston will serve the remaining two years of Simmons third term. She was one of two candidates the board recommended to council to fill the vacant seat. County Council recognized Dr. Johnstons longstanding commitment to improving the health of the community, board chair Terry Murray said. We welcome her to the board and look forward to her contributions. Doran appointed VP of quality services Beaufort Memorial has named Shawna Doran its vice president of quality services, responsible for planning and leading all quality, patient safety, risk and patient experience initiatives. For … Continue reading

Posted in Cardiology | Comments Off on Physician named to Beaufort Memorial Hospital board – Bluffton Today

Director General of Nigeria’s biotechnology agency arrested over … – Premium Times

Posted: Published on June 29th, 2017

The Economic and Financial Crimes Commission, EFCC, says it has arrested Lucy Ogbadu, the Director-General of National Biotechnology Development Agency (NABDA), over alleged N23 million fraud. The spokesperson of the commission, Wilson Uwujaren, disclosed this in a statement he issued on Thursday. Mr. Uwujaren said Ms. Ogbadu was picked up by EFCC operatives in Port Harcourt on Wednesday, following her alleged link with the Bayelsa State Director of Bio-resources Development Centre, Josiah Habu. Mr. Habu, according to him, is being investigated by the anti-graft agency in a case of fraudulent diversion of N75 million. He said investigations by the EFCC revealed that Ms. Ogbadu allegedly received N23 million through a bank account belonging to the wife of Mr. Habu, Esther Habu. The EFCC spokesperson stated that Ms. Ogbadu admitted the transaction in a voluntary statement made to the commissions investigators. Further investigations also revealed that Mrs Habu is one of the contractors with Bio-resources Development Centre, Odi, Bayelsa State. A total of N603 million has been traced to her in different deals involving over 20 directors of the centre across the country. Ogbadus involvement is being investigated. She has been duly served with bail conditions while investigations continue, Mr. Uwujaren … Continue reading

Posted in Biotechnology | Comments Off on Director General of Nigeria’s biotechnology agency arrested over … – Premium Times

AML: Cellectis testing allogenic CAR-T cell therapy – European Biotechnology

Posted: Published on June 29th, 2017

Genome editing specialist Cellectis has kicked off clinical tests in the US for the very first of-the-shelf CAR-T cell therapy in acute myeloid leukaemia. The company said it enrolled the first patient with acute myeloid leukaemia (AML) to be treated with UCART123 at Weill at Cornell Medicine, New York Presbyterian Hospital. UCART123 is a TALEN-genome edited chimeric T cell receptor targeting the CD123/IL3R antigen on the surface of blasts and dendric cells, which is administered on allogeneic donor T cells. The team of Gail J. Roboz will investigate the safety and will collect first indications for efficacy of UCART123 in patients with AML. The Phase I trial is part of a strategic translational research alliance that was formed between Cellectis and Weill Cornell Medicine in 2015. While Novartis AG and Kite Pharma are leading the CAR-T cell therapy development in AML, Cellectis hopes to overtake its competitors. It has the only approach that works with allogenic CAR-engineered T cells that could be centrally pre-manufactured in contrast to the autologous patient T cells. Those need to be isolated, engineered and expanded during the at least 14 day hospital stay of the patients to be treated making the procedure costly, lengthy and … Continue reading

Posted in Biotechnology | Comments Off on AML: Cellectis testing allogenic CAR-T cell therapy – European Biotechnology

ChineseInvestors.com, Inc.’s Wholly-owned Foreign Enterprise, CBD … – PR Newswire (press release)

Posted: Published on June 29th, 2017

The new skin care line is expected to be launched in the third calendar quarter of 2017. CBD Biotechnology Co. Ltd. plans to use multiple sales channels to implement its sales plan including Tmall, TaoBao, the Company's official website, broadcasting platforms of internet celebrities, mobile news applications, and a multi-level direct selling system in cooperation with Shangdong Yibao Biologics Co. Ltd. "Following the launch of OptHemp Ultra Premium Hemp Oil by CIIX's wholly owned U.S. subsidiary, ChineseHempOil.com, Inc., I am very pleased to announce the launch of CBD Biotechnology Co., Ltd. non-industrial hemp infused skin care line," says Summer Yun, CEO of CBD Biotechnology Co., Ltd. "CBD Biotechnology Co., Ltd. will be one of the first companies in China to incorporate hemp-based CBD into skin care products, which we believe will spark public interest. "An estimated 55,700 metric tons of industrial hemp are produced around the world each year with China, Russia, and South Korea leading in production, accounting for 70 percent of the world's industrial hemp supply. Although China is one of the leading producers of industrial hemp, the benefits to the human body have not yet been widely recognized in mainland China," says Yun. "As one of the … Continue reading

Posted in Biotechnology | Comments Off on ChineseInvestors.com, Inc.’s Wholly-owned Foreign Enterprise, CBD … – PR Newswire (press release)

Explore Innovations in Industrial Biotechnology at Upcoming … – Newswise (press release)

Posted: Published on June 29th, 2017

Newswise Industrial biotechnology scientists, educators, entrepreneurs and executives from around the globe will be convening on the University of California San Diego campus this summer to explore the latest advances and world-changing innovations heating up the white-hot field of industrial biotechnology with workshops in microbial fermentation and metabolic engineering. UC San Diego Extension will host its annual Industrial Biotechnology Workshops on Aug. 14 through 18. Participants can attend the whole program or attend the workshops on microbial fermentation or metabolic engineering separately. Now in its fifth year, this widely acclaimed educational event creates an informal, intimate environment for robust exchange of knowledge and ideas among world-class academic instructors and leaders of cutting-edge companies of every size from startup to mature, said Hugo Villar, associate dean of Professional & Continuing Education for UC San Diego Extension. Whether from California or China, biotechnology professionals attending these workshops will have a front-row seat to learn about current developments and advanced scientific skills being used to solve some the worlds most difficult problems, Villar said. Microbial Fermentation For the past four years, the workshop focused primarily on microbial fermentation, which is the transformation of feedstocks, such as plant sugars, into useful products, like fuels, … Continue reading

Posted in Biotechnology | Comments Off on Explore Innovations in Industrial Biotechnology at Upcoming … – Newswise (press release)

Karnataka IT and Biotechnology Dept Grants Rs 3.18 cr to 12 Start-ups – News18

Posted: Published on June 29th, 2017

Bengaluru: The Karnataka IT and Biotechnology department on Wednesday granted Rs 3.18 crore to fund 12 start-ups in the areas of agriculture, biotechnology, security, communications and robotics. "The dozen start-ups have been selected for funding to innovate products and solutions as they have been part of the Idea2PoC (Proof of Concept) scheme of the IT department's Start-up Cell," said an official statement in Bengaluru. The Idea2PoC is a part of the country's first multi-sector start-up policy, unveiled by the state government to encourage entrepreneurs with funding to commercialise their innovation. The start-ups with seed funding are Dr. Live Software (Rs 10 lakh), EasyKrishi (Rs 15 lakh), Lightmetrics (Rs 30 lakh), PiOctave Solutions (Rs 30 lakh), Geeksynergey Technologies (Rs 30 lakh), ispAgro Robotics (Rs 20 lakh), Astrome (Rs 30 lakh), Esyasoft (Rs 20 lakh), Geotraq Safety (Rs 45 lakh), NammaNimma Cycle Foundation (Rs 10 lakh), Sirena Technologies (Rs 48 lakh) and Selfdot Technologies (Rs 30 lakh). "Though Bengaluru is the country's IT hub, we are seeing its start-up culture spreading to other areas, including agriculture, biotechnology, security, communications, robotics and gaming rapidly. Our aim is to mentor and help them to become self-sufficient," said IT & BT Principal Secretary Gaurav Gupta … Continue reading

Posted in Biotechnology | Comments Off on Karnataka IT and Biotechnology Dept Grants Rs 3.18 cr to 12 Start-ups – News18

Chemists discover biology’s version of the Friedel-Crafts alkylation – The Biological SCENE

Posted: Published on June 29th, 2017

By chemistry standards, the Friedel-Crafts alkylation is a venerable reaction. First reported by chemists Charles Friedel and James Crafts in 1877, the reaction attaches an alkyl substituent to an aromatic ring using an alkyl halide as one of the reactants. It turns out that Nature has been doing this reaction for even longerscientists just didnt know it until now. Harvard Universitys Emily P. Balskus, Hitomi Nakamura, and Erica E. Schultz have discovered an enzyme, dubbed CylK, that accomplishes this same transformation during the biosynthesis of cylindrocyclophanes, natural products made by cyanobacteria that are toxic to cells (Nat. Chem. Bio. 2017, DOI: 10.1038/nchembio.2421). Because aromatic-alkyl linkages are such important motifs in synthetic compounds, were hoping that the enzyme we found will ultimately be useful for chemical production, says Balskus, who led the research effort. Her team also found a new type of metal-dependent halogenating enzyme, named CylC, that creates secondary alkyl chlorides. Secondary alkyl halides can be tricky to prepare in the lab because the intermediates en route to making them tend to rearrange. The same can be said for using secondary alkyl halides as reactants in the Friedel-Crafts alkylation. Secondary alkyl halides have been notoriously problematic substrates for that reaction, … Continue reading

Posted in Biology | Comments Off on Chemists discover biology’s version of the Friedel-Crafts alkylation – The Biological SCENE

Readers respond to climate activists, Washington’s biology-test twist – Pacific Northwest Inlander

Posted: Published on June 29th, 2017

Readers respond to our blog post "Washington lawmakers will likely allow high school seniors who failed state test to graduate" (6/23/17), about throwing out results of the end-of-course biology test: Susan Smith Lindsey: I am concerned about the "dumbing down" of our high school students by waiving these end of course exams. Why are the students not passing these exams? If they are unable to pass these exams are they adequately prepared for college, university, or community college or will they be required to take remedial courses thereby pushing the responsibility to the community colleges, etc., for what they should have learned in high school? Peter Hire: There's plenty of people who don't test well, others who just aren't that smart, and still others who might not need a particular area of study in their future. Didn't the shenanigans with the WASL a decade ago teach our state anything? Lauren House: Biology is not a college requirement for many students unless they plan to go into a science based field. The test is also based on standards that have been replaced for several years so it is a no-brainer to eliminate this. It has nothing to do with "dumbing down" … Continue reading

Posted in Biology | Comments Off on Readers respond to climate activists, Washington’s biology-test twist – Pacific Northwest Inlander

Molecular Biology Enzymes and Kits and Reagents Market Worth $26.7 Billion by 2025: Grand View Research, Inc. – PR Newswire (press release)

Posted: Published on June 29th, 2017

(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO) Technological advancements aimed at development of advanced products and increasing R&D investments by leading manufacturers are some of the key factors contributing to increasing demand for these enzymes, kits, and reagents. In addition, increasing adoption of molecular diagnostics is expected to serve this industry as a potential growth driver. Molecular biology enzymes, kits, and reagents are majorly used in genomics-related application areas. Increased funding for research in the field of genomics and sequencing are expected to augment growth during the forecast period. Furthermore, these products are used in the drug discovery and development stages in pharmaceutical and biopharmaceutical companies. Pharmaceutical and biotechnology companies contribute to the largest share of the end users of molecular biology enzymes, kits, and reagents. This dominant share can be attributed to increasing investments in R&D, expanding biopharmaceutical & biotechnology industry in the Asia Pacific region, and government initiatives in various countries to develop the biotechnology & pharmaceutical industry. Browse full research report with TOC on "Molecular Biology Enzymes And Kits & Reagents Market Analysis By Product (Kits and Reagents, Enzymes), By Application (PCR, Sequencing, Cloning, Epigenetics), By End User, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/molecular-biology-enzymes-kits-reagents-market Further key findings from the report … Continue reading

Posted in Biology | Comments Off on Molecular Biology Enzymes and Kits and Reagents Market Worth $26.7 Billion by 2025: Grand View Research, Inc. – PR Newswire (press release)

Page 1,673«..1020..1,6721,6731,6741,675..1,6801,690..»